1 Richeldi L. An updata on the diagnosis of tuberculsosis infection. Am J Respir Crit Care Med, 2006, 174: 736-742
[2]
2 Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med, 2007, 146: 340-354
[3]
3 Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med, 2008, 149: 177-184
[4]
4 Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis, 2006, 10: 1192-1204
[5]
5 Mancuso J D, Mazurek G H, Tribble D, et al. Discordance among commercially available disgnostics for latent tuberculosis infection. Am J Respir Crit Care Med, 2012, 185: 427-434
[6]
6 Herrera V, Perry S, Parsonnet J, et al. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis, 2011, 52: 1031-1037
[7]
7 Machingaidze S, Wiysonge C S, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J, 2011, 30: 694-700
[8]
8 Mandalakas A M, Detjen A K, Hesseling A C, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis, 2011, 15: 1018-1032
[9]
9 Ling D I, Nicol M P, Pai M, et al. Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis. Thorax, 2013, 68: 860-866
[10]
10 Sester M, Sotgiu G, Lange C, et al. Interferon-g release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2011, 37: 100-111
[11]
11 Metcalfe J Z, Everett C K, Steingart K R, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis, 2011, 204: S1120-S1129
[12]
12 Kang Y A, Lee H W, Hwang S S, et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest, 2007, 132: 959-965
[13]
13 WHO. Strategic and Technical Advisory Group for Tuberculosis (STAG-TB): report of the tenth meeting. Geneva: World Health Organization, 2010. http://www.who.int/tb/advisory_bodies/stag_tb_report_2010.pdf
[14]
14 Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest, 2012, 142: 63-75
[15]
15 Rangaka M X, Wilkinson K A, Glynn J R, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis, 2012, 12: 45-55
[16]
16 Jafari C, Emst M, Kalsdorf B, et al. Rapid dignosis of smear-negative tuberculosis by brochoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med, 2006, 174: 1048-1054
[17]
17 Jafari C, Thijsen S, Sotgiu G, et al. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a tuberculosis network European trialsgroup study. Am J Respir Crit Care Med, 2009, 180: 666-673
[18]
18 Jiang J, Shi H Z, Liang Q L, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest, 2007, 131: 1133-1141
[19]
19 Liang Q L, Shi H Z, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med, 2008, 102: 744-754
[20]
20 Tong Z H, Shi H Z. Subpopulations of helper T lymphocytes in tuberculous pleurisy. Tuberculosis (Edinb), 2013, 93: 279-284
[21]
21 Zhou Q, Chen Y Q, Qin S M, et al. Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis. Respirology, 2011, 16: 473-480
[22]
22 Kim S H, Cho O H, Park S J, et al. Diagnosis of abdominal tuberculosis by T-cell-based assays on peripheral blood and peritoneal fluid mononuclear cells. J Infect, 2009, 59: 409-415
[23]
23 Cho O H, Park K H, Park S J, et al. Rapid diagnosis of tuberculous peritonitis by T cell-based assays on peripheral blood and peritoneal fluid mononuclear cells. J Infect, 2011, 62: 462-471
[24]
24 Patel V B, Singh R, Connolly C, et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med, 2010, 182: 569-577
[25]
25 Kim S H, Chu K, Choi S J, et al. Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Vaccine Immunol, 2008, 15: 1356-1362
[26]
26 Kim S H, Cho O H, Park S J, et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis, 2010, 50: 1349-1358
[27]
27 Park K H, Cho O H, Lee E M, et al. T-cell-based assays on cerebrospinal fluid and PBMCs for rapid diagnosis of TB meningitis in non-HIV patients. Eur Respir J, 2012, 39: 768-770
[28]
28 Antonucci G, Girardi E, Raviglione M C, et al. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA, 1995, 274: 143-148
[29]
29 Huebner R E, Schein M F, Bass J B Jr. The tuberculin skin test. Clin Infect Dis, 1993, 17: 968-975
[30]
30 Richeldi L, Losi M, D''Amico R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest, 2009, 136: 198-204
[31]
31 Redelman-Sidi G, Sepkowitz K A. IFN-g release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med, 2013, 188: 422-431
[32]
32 Leidl L, Mayanja-Kizza, H, Sotgiu G, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J, 2010, 35: 619-626
[33]
33 Chiappini E, Fossi F, Bonsignori F, et al. Utility of interferon-g release assay results to monitor anti-tubercular treatment in adults and children. Clin Ther, 2012, 34: 1041-1048
[34]
34 Adetifa I M, Ota M O, Jeffries D J, et al. Interferon-g ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med, 2013, 187: 439-445
[35]
35 Denkinger C M, Pai M, Patel M, et al. Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory. J Clin Microbiol, 2013, 51: 607-610
